NARMAFOTINIB Large-Scale Manufactre Complete
(Other OTC:INNMF),(OTC US:INNMF),(AUST:ATX.AX), Successful completion of the first large-scale manufacture of narmafotinib which produced approx. 13 kg of drug Successful transition of process and production from an R&D facility to a commercial manufacturing environment – a key step in Phase-3 readiness Sufficient drug supply to support Amplia's pancreatic cancer trials and other planned studies, supporting […]